science1 distinct publisher
SINTEF ranks mRNA nanoparticles by immune uptake in fresh human donor blood
Ninety percent of drug candidates that reach human trials are never approved. A Norwegian group argues some of that triage belongs in donor blood, where nanoparticles meet the plasma proteins and immune cells that settle their fate.
Publishers:phys.org
Reality
- Evidence34
- Adoption
- Insufficient
- Hype gap+28
- Incentives68